US antitrust agencies were active in merger enforcement in 2019 and 2020, reflecting the agencies’ commitment to antitrust enforcement particularly in transactions involving nascent competitors and technologies
Insight
Merging companies: Consider social factors in US antitrust clearance
The benefits of highlighting ESG, jobs and other positive deal impacts
Insight
US antitrust spotlight on the pharmaceutical industry
Companies seeking mergers can expect scrutiny and litigation
Alert
Grants of early termination of HSR waiting period temporarily suspended by DOJ and FTC – merging parties should expect to wait the full 30 days until further announcement
Alert
FTC Announces Annual Changes to HSR Thresholds (2021)
HSR Thresholds Decline for the First Time Since 2010
